The influence of L-carnitine on methanol biotransformation in rats

Experimental and Toxicologic Pathology

Volumn 55, Issue 5, 2004, Pages 367-377

  Czech, Ewa ^a   Olszowy, Zofia ^a   Nowicka, Joanna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Biotransformation; L carnitine; Methanol; Rats

Indexed keywords

ALCOHOL DEHYDROGENASE; CARNITINE; METHANOL;

AEROBIC METABOLISM; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; BLOOD SAMPLING; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INTOXICATION; DRUG TRANSFORMATION; ENZYME INHIBITION; ENZYME SYNTHESIS; GAS CHROMATOGRAPHY; HEART MUSCLE CELL; LIVER BIOPSY; LIVER MICROSOME; NONHUMAN; RAT;

ANIMALIA;

EID: 1842577538     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00340     Document Type: Article

References (77)

1. ALBANO E: Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Rad Biol Med 2002; 32: 110-114.
2. AMODIO P, ANGELI P, et al.: Plasma carnitine levels in liver cirrhosis: relationship with nutritional status and liver damage. J Clin Chem Clin Biochem 1990; 28: 619-626.
3. ARRIGONI-MARTELLI E, CASO V: Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exptl Clin Res 2001; 27: 27-49.
4. AUWÄRTER V, SPORKERT F, et al.: Fatty acid ethyl esters as markers of alcohol consumption. Segmental hair analysis of alcoholics, social drinkers, and teetotalers. Clin Chem 2001; 47: 2114-2123.
5. BAILEY S, CUNNINGHAM C: Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Rad Biol Med 2002, 32: 11-16.
6. BEKKA R, BORRON S, et al.: Treatment of methanol and isopropanol poisoning with intravenous fomepizole. Clin Toxicol 2001; 39: 59-67.
7. BINIENDA Z, ALI S: Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol Lett 2001; 125: 67-73.
8. BOGDANIK T: Kontrowersje i trudności zwia̧zane z ostrymi zatruciami alkoholem metylowym i glikolem etylenowym. Stud Mat Monogr IMP Łódź 1983; 2: 36-46.
9. BRENT J, MCMARTIN K, et al.: Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001; 344: 424-429.
10. BURNS M, GRAUDINS A, et al.: Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med 1997; 30: 829-832.
11. CALABRESE V, RIZZA V: Effects of L-carnitine on the formation of fatty acid ethyl esters in brain and peripheral organs after short-term ethanol administration in rat. Neurochem Res 1999; 24: 79-84.
12. CALABRESE V, RIZZA V: Formation of propionate after short-term ethanol treatment and its interaction with carnitine pool in rat. Alcohol 1999; 19: 169-175.
13. CALABRESE V, SCAPAGNINI G, et al.: Effects of acetyl-L-carnitine on the formation of fatty acid ethyl esters in brain and pheripheral organs after short-therm ethanol administration in rat. Neurochem Res 2001, 26: 167-74.
14. CAMPILLO B, CHAPELAIN C, et al.: Hormonal and metabolic changes during exercise in cirrhotic patients. Metabolism 1990; 39: 18-24.
15. CEDERBAUM A: Introduction - Serial review: alcohol, oxidative stress and cell injury. Free Rad Biol Med 2001; 31: 1524-1526.
16. DAWIDEK-PIETRYKA K, DUDKA J, et al.: Inhibicja dehydrogenazy alkoholowej przez wybrane zwia̧lzki w reakcji z metanolem i glikolem etylenowym Bromat Chem Toksykol 2000; 33: 155-160.
17. Di GIACOMO C, LATTERI F, et al.: Effect of acetyl-L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem Res 1993; 18: 1157-1162.
18. FACI A, PLAA G, et al.: Chloral hydrate enhances ethanol-induced inhibition of methanol oxidation in mice. Toxicology 1998; 131: 1-7.
19. FELLER A, RUDMAN D: Role of carnitine in human nutrition. J Nutr 1988; 118: 541-547.
20. FULLER R, HOPPEL C: Elevated plasma carnitine in hepatis cirrosis. Hepatology 1983; 3: 354-358.
21. GEBICKI S, GEBICKI J: Formation of peroxides in amino acids and protein exposed to oxygen free radicals. Biochem J 1993; 289: 743-749.
22. GIRAULT CH, TAMION F, et al.: Fomepizole (4-methylpyrazole) in fatal methanol poisoning with early CT Scan cerebral lesions. Clin Toxicol 1999; 37: 777-780.
23. GUERTL B, NOEHAMMER C: Metabolic cardiomyopathies. Int J Exp Pathol 2000; 81: 349-372.
24. HAFFNER H, GRAW M: Curvilinear increase in methanol concentration after inhibition of oxidation by ethanol: significance for the investigation of endogenous methanol concentration and formation. Int J Legal Med 1998; 111: 27-31.
25. Handbook of toxicology, Vol I. Acute Toxicities, edit.: Spector W S, W B Saunders Company, Philadelphia 1956: 188.
26. HANTSON P, WALLEMACQ P, et al.: Two cases of acute methanol poisoning partially treated by oral 4-methylpyrazole. Intens Care Med 1999; 25: 528-531.
27. HAYASAKA Y, HAYASAKA S, et al.: Ocular changes after injection of methanol, formaldehyde, or formate in rabbits. Pharmacol Toxicol 2001; 89: 74-78.
28. HOPPEL C: The physiological role of carnitine, in: L-carnitine and its role in medicine: from function to therapy. edit. Ferrari R, Academic Press New York 1992: 5-19
29. JACOBSEN D, MCMARTIN K: Antidotes for methanol and ethylene glycol poisoning. Clin Toxicol 1997; 35: 127-43.
30. JACOBSEN D, SEBSTIAN C, et al.: Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. Alcohol Clin Experim Res 1996; 20: 804-809.
31. KAUR J, SHARMA D, et al.: Acetyl-L-carnitine enhances Na, K, -ATP-ase glutatione-s-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci Lett 2001; 301: 1-4.
32. KINOSHITA H, IJIRI I, et al.: Combined toxicity of methanol and formic acid: two cases of methanol poisoning. Int J Legal Med 1998; 111: 334-335.
33. KRÄHENBÜHL S: Carnitine metabolism in chronic liver disease. Life Sci 1996; 59: 1579-1599.
34. LIEBER C: Medical disorders of alcoholism. New Engl J Med 1995; 333: 1058-1065.
35. LOHINGER A: The role of L-carnitine in pregnancy and disorders of lipid metabolism. Ann Nutr Metab 2000; 44: 89-91.
36. LöSTER H, BöHM U: L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions. Molec Cell Biochem 2001; 217: 83-90.
37. LÖSTER H: Effects of L-carnitine on the heart. Ann Nutr Metab 2000; 44: 82-84.
38. LOULET J-F, LE MAY C et al.: Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acid. Biochem Soc T 2001; 29: 310-313.
39. ŁYSIAK-SZYDŁOWSKA W: Fizjologiczna rola L-karnityny w organizmie człowieka - przyczyny i skutki jej niedoboru. Pol Tyg Lek 1988; 10: 337-341.
40. MACHATA G: Uber die gaschromatographische Blutalkoholbestimmung. Blutalkohol 1967; 4: 252-260.
41. MANGANO NG, CLEMENTI G, et al.: Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats. Drugs Exp Clin Res 2000; 26: 7-12.
42. MENON N, GORES G, et al.: Pathogenesis, diagnosis and treatment of alcoholic disease. Mayo Clin Proc 2001; 76: 1021-1029.
43. MEYBURG J, SCHULTZE A, et al.: Postnatal changes in neonatal acylcarnitine profile. Pediat Res 2001; 49: 125-129.
44. MOTTARAN E, STEWART S, et al.: Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Rad Biol Med 2002; 32: 38-45.
45. MYNATT RL, SACHAN DL: Altered redox state as a basis for carnitine-mediated attenuation of ethanol oxidation in the rat. Biochem Arch 1992; 8: 345-353.
46. NAVDER KP, BARAONA E, et al.: Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr 1997; 127: 1800-1806.
47. OYAMA Y, SAKAI H, et al.: Cytotoxic effects of methanol, formaldehyde, and formate on dissociated rat thymocytes: A possibility of aspartame toxicity. Celle Biol Toxicol 2002; 18: 43-50.
48. PANDEY C, AGARWAL A, et al.: Toxicity of ingested formalin and its management. Hum Exper Toxicol 2000; 19: 360-366.
49. PAULSON D: Carnitine deficienty - induced cardiomyopathy. Mol Cell Biochem 1998; 180: 33-41.
50. PIETRUSZKO R: Human liver alcohol dehydrogenase - inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. Biochem Pharmacol 1975; 24: 1603-1607.
51. PRAGST F, AUWAERTER V, et al.: Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci Int 2001; 121: 76-88.
52. RAMSAY R, GANDOUR R, et al.: Molecular enzymology of carnitine transfer and transport. Review Bioch Bioph Acta 2001; 1546: 21-43.
53. RöSSLE C, KOHSE KP, et al.: An improved method for the determination of free and esterified carnitine. Clin Chim Acta 1985; 149: 263-268.
54. RUDMAN D, SEWELL C, et al.: Deficiency of carnitine in cachectic cirrhotic patients. J Clin Invest 1977; 60: 716-723.
55. SACHAN DS, BERGER R: Attenuation of ethanol metabolism by supplementary carnitine in rats. Alcohol 1987; 4: 31-35.
56. SACHAN DS, BERGER R: Specifity of carnitine in attenuation of ethanol metabolism in rat. Biochem Arch 1993; 9: 141-146.
57. SACHAN DS, MYNATT R.: Wheat gluten-based diet retarted ethanol metabolism by altering alcohol dehydrogenase and not carnitine status in adult rats. J Am Coll Nutr 1993; 12: 170-175.
58. SACHAN DS, CHA YS: Acetylcarnitine inhibits alcohol dehydrogenase. Biochem Biophys Res Commun 1994; 203: 1496-1501.
59. SARKOLA T, ERIKSSON P: Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans. Alcohol Clin Exper Res 2001; 25: 513-516.
60. SARKOLA T, ILES M, et al.: Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: effect of 4-methylpyrazole. Alcohol Clin Exp Res 2002; 26: 239-245.
61. SKRZYDLEWSKA E, FARBISZEWSKI R: Glutathione consumption and inactivation of glutathione-related enzymes in liver, erythrocytes and serum of rats after methanol intoxication. Arch Toxicol 1997; 71: 741-745.
62. SKRZYDLEWSKA E, SZMITKOWSKI M, et al.: Activity of cathepsin G, elastase, and their inhibitors in plasma during methanol intoxication. J Toxicol Environ 1999; 57: 431-442.
63. SKRZYDLEWSKA E, SZYNAKA B: Ultrastructural evaluation of hepatocytes membranes and changes in cytostolic enzymes distribution in methanol intoxication. Rocz Akad Med. Białyst 1997; 42 (Suppl. 2): 35-42.
64. SKRZYDLEWSKA E: Toksyczne działanie formaldehydu. Bromat Chem Toksykol 1993; 26: 65-71.
65. SPANIOL M, BROOKS H, et al.: Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 2001; 268: 1876-1887.
66. SUWAKI H, KALANT H, et al.: Recent research on alcohol tolerance and dependence. Alcohol Clin Exp Res 2001; 25: 189S-196S.
67. TACCONI M: Involvement of carnitine in Rey's and Reye-like syndromes. in: Carnitine today, edit. De Simone C, Famularo G, 1997: 187-194.
68. TAINAKA H, NAITO T, et al.: Modulation of ethanol-mediated CYP2E1 induction by clofibrate and L-carnitine in rat liver. Biol Pharm Bull 1993; 16: 1240-1243.
69. TENG S, BEARD K, et al.: The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem Biol Interact 2001; 130-132: 285-296.
70. THEPLY T: The toxicity of methanol. Life Science 1991; 48: 1031-1041.
71. TSUKAMOTO H, Lu S: Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001; 15: 1335-1349.
72. TUMA D: Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Rad Biol Med 2002; 32: 303-308.
73. VAZ F, WANDERS J: Carnitine biosynthesis in mammals. Biochem J 2002; 361: 417-429.
74. VESELA E, RACEK J, et al.: Effect of L-carnitine supplementation in hemodialysis patients. Nephron 2001; 88: 218-223.
75. WANG R, NAKAJIMA T, et al.: Trichloroetylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology 1999; 132: 9-18.
76. ZORZANO A, HERRERA E: Differences in kinetic characteristics and in sensivity to inhibitors between human and rat liver alcohol dehydrogenase and aldehyde dehydrogenase. Gen Pharmac 1990; 21: 697-702.
77. ZURBRIGGEN E: L-carnitine: historical review. Ann Nutr Metab 2000; 44: 78-79.